Safety concerns: AstraZeneca withdraws COVID-19 vaccine from circulation

Pharmaceutical giant, AstraZeneca has formally asked the European Medicines Agency to withdraw its COVID-19 vaccine authorisation. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorisation holder.” According to Africanews, the vaccine, initially approved in January…

Read the full story here

COVID-19 continues to circulate, evolve with important genetic & antigenic evolution of spike protein – WHO

Key points SARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein. The objective of an update to COVID-19 vaccine antigen composition is to enhance vaccine-induced immune responses to circulating SARS-CoV-2 variants. As the virus is expected to continue to evolve from JN.1, the TAG-CO-VAC advises the use of…

Read the full story here